I 
119TH CONGRESS 
1ST SESSION H. R. 6401 
To require the Secretary of Health and Human Services to submit to Con-
gress a report on the option to elect to pay cost-sharing under a prescrip-
tion drug plan or MA-PD plan in monthly capped amounts. 
IN THE HOUSE OF REPRESENTATIVES 
DECEMBER 3, 2025 
Mrs. KIGGANS of Virginia (for herself and Mr. KRISHNAMOORTHI) introduced 
the following bill; which was referred to the Committee on Energy and 
Commerce, and in addition to the Committee on Ways and Means, for 
a period to be subsequently determined by the Speaker, in each case for 
consideration of such provisions as fall within the jurisdiction of the com-
mittee concerned 
A BILL 
To require the Secretary of Health and Human Services 
to submit to Congress a report on the option to elect 
to pay cost-sharing under a prescription drug plan or 
MA-PD plan in monthly capped amounts. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Increasing Medication 
Access for Seniors Act of 2025’’. 
VerDate Sep 11 2014 
23:55 Dec 03, 2025
Jkt 069200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H6401.IH
H6401
ssavage on LAPJG3WLY3PROD with BILLS
SEC. 2. REPORTS ON MEDICARE PART D MONTHLY CAPPED 
COST-SHARING OPTION. 
(a) REPORTS.—Not later than the date that is 3 
months after the date of the enactment of this section, 
not less frequently than every 3 months thereafter until 
the date that is 1 year after the date of the enactment 
of this section, and not less frequently than annually 
thereafter until March 31, 2031, the Secretary of Health 
and Human Services (in this section referred to as the 
‘‘Secretary’’) shall submit to Congress a report on the op-
tion to elect to pay cost-sharing under a prescription drug 
plan or MA–PD plan in monthly capped amounts under 
section 1860D–2(b)(2)(E)(i) of the Social Security Act 
(42 U.S.C. 1395w–102(b)(2)(E)(i)), including, with re-
spect to the 1-year period ending on the date that is 1 
year before the date on which the report is required to 
be submitted— 
(1) the number of Medicare part D enrollees 
who made such an election during such period, in-
cluding— 
(A) the number of such enrollees residing 
in each census region (as designated by the Bu-
reau of the Census); 
(B) the number of such enrollees who are 
enrolled in a prescription drug plan; and 
VerDate Sep 11 2014 
23:55 Dec 03, 2025
Jkt 069200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H6401.IH
H6401
ssavage on LAPJG3WLY3PROD with BILLS
(C) the number of such enrollees who are 
enrolled in an MA–PD plan; 
(2) an estimate of the number of Medicare part 
D enrollees who did not make such an election and 
incurred out-of-pocket costs with respect to covered 
part D drugs during such period that make it likely 
such enrollees may benefit from making such an 
election, as determined by the Secretary; 
(3) a description of any steps taken by the Sec-
retary during such period to implement a mechanism 
to allow a Medicare part D enrollee to make such 
election at the point-of-sale of a covered part D 
drug, including information on how such a mecha-
nism may be made available for every Medicare part 
D enrollee; 
(4) a description of each method used by the 
Secretary during such period to facilitate making 
such an election, including— 
(A) the Medicare.gov website; 
(B) the notice distributed pursuant to sec-
tion 1804(a) of the Social Security Act (42 
U.S.C. 1395b–2(a)) (commonly known as the 
Medicare & You handbook); 
(C) the toll-free telephone number 1–800– 
MEDICARE; and 
VerDate Sep 11 2014 
23:55 Dec 03, 2025
Jkt 069200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H6401.IH
H6401
ssavage on LAPJG3WLY3PROD with BILLS
(D) resources for health care providers; 
and 
(5) a description of any other outreach efforts 
the Secretary conducted with respect to such option 
during such period, including outreach to— 
(A) health care provider associations and 
societies; 
(B) patient and consumer advocacy groups 
that represent Medicare part D enrollees; 
(C) pharmacy benefit managers; 
(D) pharmacies; and 
(E) health insurance providers. 
(b) DEFINITIONS.—In this section: 
(1) MEDICARE PART D ENROLLEE.—The term 
‘‘Medicare part D enrollee’’ means an individual en-
rolled in a prescription drug plan or MA–PD plan 
under part D of title XVIII of the Social Security 
Act (42 U.S.C. 1395w–101 et seq.). 
(2) MEDICARE
PART
D
TERMS.—The terms 
‘‘covered part D drug’’, ‘‘prescription drug plan’’, 
and ‘‘MA–PD plan’’ have the meanings given each 
such term in part D of title XVIII of the Social Se-
curity Act (42 U.S.C. 1395w–101 et seq.). 
Æ 
VerDate Sep 11 2014 
23:55 Dec 03, 2025
Jkt 069200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6301
E:\BILLS\H6401.IH
H6401
ssavage on LAPJG3WLY3PROD with BILLS